Table 4.
Statistically significant DMRs (FDR < 0.05) associated with PBDE serum levels in samples from 313 healthy controls.
| Associationa | Chrb | DMR start | DMR end | CpGc | Nearby gene | Gene region | Peak Pd | FDRe | Meanf diff |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| BDE-153 | 12 | 9217079 | 9217907 | 10 | A2M-AS1 | TSS200 | 8×10−6 | 0.0002 | 0.0109 |
| BDE-153 | 15 | 45669010 | 45671347 | 19 | GATM | TSS1500 | 1×10−3 | 0.0379 | −0.0029 |
| BDE-153 | 10 | 134777785 | 134779406 | 8 | LINC01168 | TSS1500 | 3×10−6 | 0.0056 | −0.0090 |
| BDE-100 | 10 | 134777785 | 134779406 | 8 | LINC01168 | TSS1500 | 1×10−4 | 0.0214 | −0.0081 |
| BDE-47 | 10 | 134777785 | 134778648 | 6 | LINC01166 | TSS1500 | 3×10−3 | 0.0213 | 0.0067 |
| BDE-100 | 10 | 134150119 | 134151130 | 12 | LRRC27 | TSS200 | 6×10−6 | 0.0049 | −0.0378 |
| BDE-47 | 10 | 134150119 | 134151130 | 12 | LRRC27 | TSS200 | 2×10−5 | 0.0030 | −0.0388 |
| BDE-153 | 10 | 134150119 | 134151130 | 12 | LRRC27 | TSS200 | 3×10−3 | 0.0164 | −0.0252 |
| BDE-153 | 22 | 18463400 | 18463646 | 4 | MICAL3 | 5’UTR | 1×10−5 | 0.0224 | −0.0094 |
| BDE-100 | 12 | 124873347 | 124874007 | 5 | NCOR2 | TSS1500 | 7×10−4 | 0.0056 | 0.0299 |
| BDE-153 | 1 | 163037784 | 163039184 | 16 | RGS4 | 5’UTR | 2×10−5 | 0.0399 | −0.0172 |
| BDE-153 | 1 | 3585225 | 3585587 | 5 | TP73 | TSS1500 | 2×10−3 | 0.0051 | −0.0181 |
| BDE-100 | 10 | 5406143 | 5407594 | 13 | UCN3 | TSS200 | 2×10−4 | 0.0178 | −0.0113 |
| BDE-153 | 10 | 5406143 | 5407594 | 12 | UCN3 | TSS200 | 4×10−4 | 0.0140 | −0.0029 |
Association between a BDE level and multiple CpG sites in a region tested by DMRcate method
Chromosome position is based on GRCh37/(hg19)
Number of CpG sites in a DMR(differentially methylated region)
smallest p-value among multiple CpG sites in a region associated with BDE exposure from identification of individual differentially methylation site
overall regional significance of a DMR, Benjamini-Hochberg adjusted for the total number of tested regions agglomerated from groups of individual significant CpG sites
Mean methylation changes across all CpG sites in a region in relation to one unit of log2(BDE) in the primary analysis or mean methylation difference between samples with top and bottom 25% BDE concentration in the secondary analysis(italic font).